Hostname: page-component-89b8bd64d-4ws75 Total loading time: 0 Render date: 2026-05-09T14:34:11.889Z Has data issue: false hasContentIssue false

Development of robust normative data for the neuropsychological assessment of Greek older adults

Published online by Cambridge University Press:  29 January 2024

Xanthi Arampatzi
Affiliation:
Lab of Cognitive Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece Athens Alzheimer’s Association, Athens, Greece
Eleni S. Margioti
Affiliation:
Lab of Cognitive Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece Athens Alzheimer’s Association, Athens, Greece
Lambros Messinis
Affiliation:
Lab of Cognitive Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece
Mary Yannakoulia
Affiliation:
Department of Nutrition and Dietetics, Harokopio University, Athens, Greece
Georgios Hadjigeorgiou
Affiliation:
School of Medicine, University of Cyprus, Nicosia, Cyprus
Efthimios Dardiotis
Affiliation:
School of Medicine, University of Thessaly, Larissa, Greece
Paraskevi Sakka
Affiliation:
Athens Alzheimer’s Association, Athens, Greece
Nikolaos Scarmeas
Affiliation:
1st Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece Department of Neurology, Taub Institute for Research in Alzheimer’s Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Columbia University, New York, USA
Mary H. Kosmidis*
Affiliation:
Lab of Cognitive Neuroscience, School of Psychology, Aristotle University of Thessaloniki, Thessaloniki, Greece
*
Corresponding author: M. H. Kosmidis; Email: kosmidis@psy.auth.gr
Rights & Permissions [Opens in a new window]

Abstract

Objective:

Normative data for older adults may be tainted by inadvertent inclusion of undiagnosed individuals at the very early stage of a neurodegenerative process. To avoid this pitfall, we developed norms for a cohort of older adults without MCI/dementia at 3-year follow-up.

Methods:

A randomly selected sample of 1041 community-dwelling individuals (age ≥ 65) received a full neurological and neuropsychological examination on two occasions [mean interval = 3.1 (SD = 0.9) years].

Results:

Of these, 492 participants (Group 1; 65–87 years old) were without dementia on both evaluations (CDR=0 and MMSE ≥ 26); their baseline data were used for norms development. Group 2 (n = 202) met the aforementioned criteria only at baseline, but not at follow-up. Multiple linear regressions included demographic predictors for regression-based normative formulae and raw test scores as dependent variables for each test variable separately. Standardized scaled scores and stratified discrete norms were also calculated. Group 2 performed worse than Group 1 on most tests (p-values < .001–.021). Education was associated with all test scores, age with most, and sex effects were consistent with the literature.

Conclusions:

We provide a model for developing sound normative data for widely used neuropsychological tests among older adults, untainted by potential early, undiagnosed cognitive impairment, reporting regression-based, scaled, and discrete norms for use in clinical settings to identify cognitive decline in older adults. Additionally, our co-norming of a variety of tests may enable intra-individual comparisons for diagnostic purposes. The present work addresses the challenge of developing robust normative data for neuropsychological tests in older adults.

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2024. Published by Cambridge University Press on behalf of International Neuropsychological Society
Figure 0

Table 1. Demographic and clinical characteristics during the baseline evaluation for Group 1 and Group 2

Figure 1

Table 2. Group comparisons (means and SDs) on neuropsychological test variables and between-group effect sizes (Cohen’s d) (continued)

Figure 2

Table 3. Regression-based equations to calculate adjusted scores

Supplementary material: File

Arampatzi et al. supplementary material

Arampatzi et al. supplementary material
Download Arampatzi et al. supplementary material(File)
File 311.3 KB